Featured Jobs
|
BPAS
|
|
DWC ERISA Consultants LLC
|
|
BPAS
|
|
EPIC RPS
|
|
Compensation Strategies Group, Ltd.
|
|
Retirement Combo Plan Administrator Heritage Pension Advisors, Inc.
|
|
Defined Benefit Specialist II or III Nova 401(k) Associates
|
|
Merkley Retirement Consultants
|
|
Distributions Processor - Qualified Retirement Plans Anchor 3(16) Fiduciary Solutions, LLC
|
|
The Pension Source
|
|
July Business Services
|
|
Nova 401(k) Associates
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
Search the News Archive
|
84 Matching News Items |
| 1. |
FierceHealthcare
May 29, 2025
"Express Scripts argues that the bill ... would have the effect of shutting down many pharmacies across [the state].... Express Scripts is bringing the suit to prevent this harm and because it believes 'the law violates multiple provisions of federal law,' the PBM said in the complaint." [Express Scripts, Inc. v. Arkansas State Board of Pharmacy, No. 25-0520 (E.D. Ark. complaint filed May 29, 2025); CVS Pharmacy, Inc. v. Arkansas State Board of Pharmacy, No. 25-0524 (E.D. Ark. complaint filed May 29, 2025)]
|
| 2. |
Duane Morris LLP
Oct. 1, 2024
"Express Scripts' 58-page complaint challenges the [FTC's interim report], alleging, among other things, that the FTC ignored dispositive evidence in drawing its conclusions and exhibited unfair bias.... The complaint requests, among other things, declaratory judgments finding the interim report to be unlawful, an order vacating the interim report and an injunction recusing [FTC Chair Lina Kahn] from all FTC action pertaining to Express Scripts." [Express Scripts v. FTC, No. 24-1263 (E.D. Mo. complaint filed Sep. 17, 2024)]
|
| 3. |
FierceHealthcare
June 6, 2024
"[Cigna, the parent company of Express Scripts,] said in its lawsuit that the company would be 'immediately and irreparably harmed' if Bricker were allowed to join CVS given her experience at Express Scripts.... Cigna argued that if Bricker were allowed to join CVS she would 'inevitably' be asked to reveal trade secrets from her former company. Her knowledge of Express Scripts' business could be used by CVS to develop products and offerings that compete with it directly." [Cigna Corp. v. Bricker, No. 23-2455 (8th Cir. Jun. 5, 2024)]
|
| 4. |
National Community Pharmacists Association [NCPA]
Jan. 10, 2024
"The lawsuit ... claims that Express Scripts used its dominant market position to push rival PBMs to impose excessive back-end fees on pharmacies and then share the revenue with Express Scripts." [Osterhaus Pharmacy, Inc. v. Express Scripts Inc., No. 24-0039 (W.D. Wash. complaint filed Jan. 9, 2024)]
|
| 5. |
Reuters; registration may be required
Sept. 17, 2024
"Pharmacy benefit manager Express Scripts sued the [FTC] over the regulator's recent drug pricing report, calling the report's conclusion that the prescription middlemen raise drug costs defamatory.... The FTC said in the July report that market consolidation has led to PBMs favoring their own affiliated businesses, which creates conflicts of interest that prevent smaller independent pharmacies from staying competitive by steering patients away from them." [Express Scripts v. FTC, No. 24-1263 (E.D. Mo. complaint filed Sep. 17, 2024)]
|
| 6. |
Solutions Law Press
Sept. 17, 2024
"Express Scripts characterizes the FTC Report as 'unfair, biased, erroneous, and defamatory.' ... Due to these alleged false conclusions, the Complaint charges that the FTC Report violates federal and state law several times over[.]" [Express Scripts v. FTC, No. 24-1263 (E.D. Mo. complaint filed Sep. 17, 2024)]
|
| 7. |
Fierce Pharma
Aug. 27, 2024
"When CVS Caremark removed AbbVie’s Humira from its national commercial formularies back in April, biosimilar prescriptions picked up at a whirlwind pace. Now, Cigna’s Express Scripts is following suit in a move that could further chip away at Humira’s market share. Express Scripts, which is Cigna’s pharmacy benefit unit, is removing branded Humira from its largest commercial formularies come 2025 in favor of biosimilar options from Teva, Sandoz and Boehringer Ingelheim."
|
| 8. |
National Community Pharmacists Association [NCPA]
July 15, 2020
"The suit, filed on behalf of the Ohio Highway Patrol Retirement System, seeks to recover unspecified damages from Express Scripts, which had been the PBM for HPRS' health plans since 2010. 'This particular PBM egregiously charged for services it didn't deliver,' [Ohio Attorney General Dave Yost] said. 'Its repeated breaches cost Ohioans millions, and we want our money back.' " [Ohio Highway Patrol Retirement System v. Express Scripts, Inc., No. AM-20CV004504 (Franklin Cty. Ohio, complaint filed Jul. 13, 2020)]
|
| 9. |
American Journal of Managed Care
Apr. 3, 2019
"Cigna and its pharmacy benefit manager Express Scripts [are] launching a program for patients with diabetes in its commercial plans so that they pay no more than $25 for a 30-day supply of insulin.... [T]he average out-of-pocket (OOP) cost for insulin was $41.50 for a 30-day supply last year; under the new program, eligible patients will save approximately 40%."
|
| 10. |
Reuters
Oct. 17, 2018
"The new migraine drugs were approved for the U.S. market within a few months of each other this year. That gave Express Scripts more leverage in demanding a discount in exchange for putting a therapy on its 'formulary,' or list of covered drugs.... All three drugs have a list price of $575 a month, or $6,900 a year."
|
| Next » |
|
Syntax Enhancements for Standard Searches
|